Javascript must be enabled to continue!
In vivo response of Tγδ cells against non-bilayer phospholipid arrangements 2858
View through CrossRef
Abstract Description
Systemic lupus erythematosus (SLE) is a chronic autoimmune condition characterized by diverse clinical presentations, with its onset mechanisms still largely unknown. Our research team suggests that SLE and related autoimmune disorders are linked to alterations in cell membranes, in which stable non-bilayer phospholipid arrangements (NPA) trigger the formation of autoantibodies. Therefore, this study analyzed the in vivo response of Tγδ cells to NPA in a mouse model of lupus induced by the administration of liposomes bearing NPA. We analyzed Tγδ cells from the spleen and mesenteric lymph nodes using flow cytometry to evaluate their activation, cell cycle, proliferation, cytokine production, and mitochondrial type at 5, 10, and 15 days post-NPA administration. Anti-NPA IgG antibodies were observed by day 5 post-injection of liposomes bearing NPA, with increasing levels over time. Tγδ cells in mice administered with liposomes showed a statistically significant rise in their total numbers throughout the study in the spleen and at day 10 in the mesenteric lymph nodes compared to those administrated with Tris-saline solution. These cells were primarily found in the S and G2 phases of the cell cycle, exhibited metabolic reprogramming due to mitochondrial fission, and predominantly produced IL-4 and IFNγ. Our results suggest that Tγδ cells are involved in the mechanisms that drive the adaptive immune response and may play a role in generating high-affinity anti-NPA antibodies.
Funding Sources
This study was supported by grants from Instituto Politécnico Nacional (SIP20241225, SIP20241230, and SIP20241234).
Topic Categories
Basic Autoimmunity (BA)
Title: In vivo response of Tγδ cells against non-bilayer phospholipid arrangements 2858
Description:
Abstract Description
Systemic lupus erythematosus (SLE) is a chronic autoimmune condition characterized by diverse clinical presentations, with its onset mechanisms still largely unknown.
Our research team suggests that SLE and related autoimmune disorders are linked to alterations in cell membranes, in which stable non-bilayer phospholipid arrangements (NPA) trigger the formation of autoantibodies.
Therefore, this study analyzed the in vivo response of Tγδ cells to NPA in a mouse model of lupus induced by the administration of liposomes bearing NPA.
We analyzed Tγδ cells from the spleen and mesenteric lymph nodes using flow cytometry to evaluate their activation, cell cycle, proliferation, cytokine production, and mitochondrial type at 5, 10, and 15 days post-NPA administration.
Anti-NPA IgG antibodies were observed by day 5 post-injection of liposomes bearing NPA, with increasing levels over time.
Tγδ cells in mice administered with liposomes showed a statistically significant rise in their total numbers throughout the study in the spleen and at day 10 in the mesenteric lymph nodes compared to those administrated with Tris-saline solution.
These cells were primarily found in the S and G2 phases of the cell cycle, exhibited metabolic reprogramming due to mitochondrial fission, and predominantly produced IL-4 and IFNγ.
Our results suggest that Tγδ cells are involved in the mechanisms that drive the adaptive immune response and may play a role in generating high-affinity anti-NPA antibodies.
Funding Sources
This study was supported by grants from Instituto Politécnico Nacional (SIP20241225, SIP20241230, and SIP20241234).
Topic Categories
Basic Autoimmunity (BA).
Related Results
Immunomodulation des lymphocytes Vγ9Vδ2 dans les leucémies aigües
Immunomodulation des lymphocytes Vγ9Vδ2 dans les leucémies aigües
Chez l’adulte, les leucémies aigües (LA) myéloïde (LAM) ou lymphoblastique (LAL) représentent respectivement 80% et 20% des LA et sont associées à un mauvais pronostic avec une sur...
Phospholipid transfer protein deficiency in mice impairs macrophage reverse cholesterol transport
in vivo
Phospholipid transfer protein deficiency in mice impairs macrophage reverse cholesterol transport
in vivo
Phospholipid transfer protein is expressed in various cell types and secreted into plasma, where it transfers phospholipids between lipoproteins and modulates the composition of hi...
From Challenges to Advancement for Bilayer Tablet Technology as Drug Delivery System
From Challenges to Advancement for Bilayer Tablet Technology as Drug Delivery System
Bilayer tablet technology is in focus because it advantageous for combination therapy, for combining two different release profile and it gives patent novelty to existing dosage. H...
Successful transfection of Lymphoblastoid cell line (Preprint)
Successful transfection of Lymphoblastoid cell line (Preprint)
BACKGROUND
Immortalization is the stage that the cell goes through before full transformation [1]. Human resting B lymphocytes from peripheral blood are eas...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
Phospholipids
Phospholipids
Peripheral cholesterol can be transported back to liver by acceptors, particularly HDL, for disposal. The properties of cholesterol acceptors have been studied extensively. It has ...
Ex-Vivo Drug Response Profiling for Tailoring Treatment in Hematologic Malignancies: The Prospective Non-Interventional SMART-Trial
Ex-Vivo Drug Response Profiling for Tailoring Treatment in Hematologic Malignancies: The Prospective Non-Interventional SMART-Trial
Introduction
Ex-vivo drug response profiling (DRP) represents a promising strategy to better understand the tumor's pathway dependencies, genotype-phenotype associat...
Long-Term Dormant Cells in Acute Myeloid Leukemia Patient-Derived Xenografts Display Reversible Treatment Resistance, but Are Not Enriched for Leukemia-Initiating Cells
Long-Term Dormant Cells in Acute Myeloid Leukemia Patient-Derived Xenografts Display Reversible Treatment Resistance, but Are Not Enriched for Leukemia-Initiating Cells
Abstract
Introduction
Leukemia-initiating cells (LIC) are considered the source of therapy resistance and relapse, including in acute myeloid leukemia...

